| [1] |
Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045 [J]. Diabetes Res Clin Pract, 2018, 138:271-281.
|
| [2] |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013, 310(9):948-959.
|
| [3] |
Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008 [J]. JAMA, 2010, 304(6):649-656.
|
| [4] |
Kandarakis SA, Piperi C, Topouzis F, et al. Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases [J]. Prog Retin Eye Res, 2014, 42:85-102.
|
| [5] |
Maeda S, Matsui T, Ojima A, et al. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products [J]. Nutr Res, 2014, 34(9):807-813.
|
| [6] |
Sasai Y, Iwakawa K, Yanagida K, et al. Advanced glycation endproducts stimulate renal epithelial cells to release chemokines that recruit macrophages, leading to renal fibrosis [J]. Biosci Biotechnol Biochem, 2012, 76(9):1741-1745.
|
| [7] |
Deng X, Sun L, Lai X, et al. Tea polypeptide ameliorates diabetic nephropathy through RAGE and NF-kappa B signaling pathway in type 2 diabetes mice [J]. J Agric Food Chem, 2018, 66(45):11957-11967.
|
| [8] |
Lewko B, Latawiec E, Maryn A, et al. Osmolarity and glucose differentially regulate aldose reductase activity in cultured mouse podocytes [J]. Exp Diabetes Res, 2011, 2011:278963.
|
| [9] |
Cheng CL, Tang Y, Zheng Z, et al. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes [J]. Clin Invest Med, 2012, 35(5):E282.
|
| [10] |
Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications [J]. Cell Death Dis, 2018, 9(2):119.
|
| [11] |
Li J, Wang JJ, Zhang SX. NADPH oxidase 4-derived H2O2 promotes aberrant retinal neovascularization via activation of VEGF receptor 2 pathway in oxygen-induced retinopathy [J]. J Diabetes Res, 2015, 2015:963289.
|
| [12] |
Geraldes P, King GL. Activation of protein kinase C isoforms and its impact on diabetic complications [J]. Circ Res, 2010, 106(8):1319-1331.
|
| [13] |
Parveen A, Kim JH, Oh BG, et al. Phytochemicals: target-based therapeutic strategies for diabetic retinopathy [J]. Molecules, 2018, 23(7):E1519.
|
| [14] |
Liu H, Cai M. Effect of probucol on hemodynamics, rheology and blood lipid of diabetic retinopathy [J]. Exp Ther Med, 2018, 15(4):3809-3814.
|
| [15] |
Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes [J]. N Engl J Med, 2009, 361(1):40-51.
|
| [16] |
Sun CY, Lee CC, Hsieh MF, et al. Clinical association of circulating VEGF-B levels with hyperlipidemia and target organ damage in type 2 diabetic patients [J]. J Biol Regul Homeost Agents, 2014, 28(2):225-236.
|
| [17] |
Gupta N, Mansoor S, Sharma A, et al. Diabetic retinopathy and VEGF [J]. Open Ophthalmol J, 2013, 7:4-10.
|
| [18] |
Veron D, Reidy KJ, Bertuccio C, et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease [J]. Kidney Int, 2010, 77(11):989-999.
|
| [19] |
Oltean S, Qiu Y, Ferguson JK, et al. Vascular endothelial growth factor-A165b is protective and restores endothelial glycocalyx in diabetic nephropathy [J]. J Am Soc Nephrol, 2015, 26(8):1889-1904.
|
| [20] |
Arar NH, Freedman BI, Adler SG, et al. Heritability of the severity of diabetic retinopathy: the FIND-Eye study [J]. Invest Ophthalmol Vis Sci, 2008, 49(9):3839-3845.
|
| [21] |
Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy [J]. Diabetes, 2007, 56(4):1160-1166.
|
| [22] |
Stem MS, Gardner TW. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications [J]. Curr Med Chem, 2013, 20(26):3241-3250.
|
| [23] |
Liu H, Ren JG, Cooper WL, et al. Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site [J]. Proc Natl Acad Sci USA, 2004, 101(17):6605-6610.
|
| [24] |
Klein R, Knudtson MD, Klein BE, et al. The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes [J]. Diabetologia, 2010, 53(8):1638-1646.
|
| [25] |
El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Retinopathy as a predictor of other diabetic complications [J]. Int Ophthalmol, 2001, 24(1):1-11.
|
| [26] |
He F, Xia X, Wu XF, et al. Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis [J]. Diabetologia, 2013, 56(3):457-466.
|
| [27] |
Liang S, Zhang XG, Cai GY, et al. Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis [J]. PLoS One, 2013, 8(5):e64184.
|
| [28] |
Chang TI, Park JT, Kim JK, et al. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease [J]. Diabetes Res Clin Pract, 2011, 92(2):198-204.
|
| [29] |
Oh SW, Kim S, Na KY, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy [J]. Diabetes Res Clin Pract, 2012, 97(3):418-424.
|
| [30] |
Wong TY, Choi PC, Szeto CC, et al. Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies [J]. Diabetes Care, 2002, 25(5):900-905.
|
| [31] |
Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature [J]. Diabetologia, 1996, 39(12):1638-1645.
|
| [32] |
Hung CC, Lin HY, Hwang DY, et al. Diabetic retinopathy and clinical parameters favoring the presence of diabetic nephropathy could predict renal outcome in patients with diabetic kidney disease [J]. Sci Rep, 2017, 7(1):1236.
|
| [33] |
Zhang J, Wang Y, Li L, et al. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy [J]. Ren Fail, 2018, 40(1):243-251.
|
| [34] |
Jeng CJ, Hsieh YT, Yang CM, et al. Diabetic retinopathy in patients with diabetic nephropathy: development and progression [J]. PLoS One, 2016, 11(8):e0161897.
|
| [35] |
Wolf G, Muller N, Mandecka A, et al. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus [J]. Clin Nephrol, 2007, 68(2):81-86.
|
| [36] |
Chen YH, Chen HS, Tarng DC. More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients [J]. Diabetes Care, 2012, 35(4):803-808.
|
| [37] |
Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments [J]. Int J Mol Sci, 2018, 19(6):E1816.
|
| [38] |
Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. Ⅱ. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years [J]. Arch Ophthalmol, 1984, 102(4):520-526.
|
| [39] |
Varma R, Torres M, Pena F, et al. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study [J]. Ophthalmology, 2004, 111(7):1298-1306.
|
| [40] |
Parving HH, Mogensen CE, Thomas MC, et al. Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study [J]. QJM, 2005, 98(2):119-126.
|
| [41] |
Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study [J]. BMJ, 2004, 328(7448):1105.
|
| [42] |
Klein R, Zinman B, Gardiner R, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study [J]. Diabetes, 2005, 54(2):527-533.
|
| [43] |
Man RE, Sasongko MB, Wang JJ, et al. The association of estimated glomerular filtration rate with diabetic retinopathy and macular edema [J]. Invest Ophthalmol Vis Sci, 2015, 56(8):4810-4816.
|
| [44] |
KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease [J]. Am J Kidney Dis, 2007, 49(2 Suppl 2):S12-S154.
|
| [45] |
Christensen PK, Larsen S, Horn T, et al. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy [J]. Kidney Int, 2000, 58(4):1719-1731.
|
| [46] |
Horvatic I, Tisljar M, Kacinari P, et al. Non-diabetic renal disease in Croatian patients with type 2 diabetes mellitus [J]. Diabetes Res Clin Pract, 2014, 104(3):443-450.
|
| [47] |
Zhou J, Chen X, Xie Y, et al. A differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases [J]. Nephrol Dial Transplant, 2008, 23(6):1940-1945.
|
| [48] |
Liu MY, Chen XM, Sun XF, et al. Validation of a differential diagnostic model of diabetic nephropathy and non-diabetic renal diseases and the establishment of a new diagnostic model [J]. J Diabetes, 2014, 6(6):519-526.
|
| [49] |
Parving HH, Gall MA, Skott P, et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients [J]. Kidney Int, 1992, 41(4):758-762.
|
| [50] |
Dong Z, Wang Y, Qiu Q, et al. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients [J]. Diabetes Res Clin Pract, 2016, 121:112-118.
|
| [51] |
Sacks FM, Hermans MP, Fioretto P, et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries [J]. Circulation, 2014, 129(9):999-1008.
|
| [52] |
Shah K, Gandhi A, Natarajan S. Diabetic retinopathy awareness and associations with multiple comorbidities: insights from DIAMOND study [J]. Indian J Endocrinol Metab, 2018, 22(1):30-35.
|
| [53] |
Yun KJ, Kim HJ, Kim MK, et al. Risk factors for the development and progression of diabetic kidney disease in patients with type 2 diabetes mellitus and advanced diabetic retinopathy [J]. Diabetes Metab J, 2016, 40(6):473-481.
|
| [54] |
de Carvalho JA, Tatsch E, Hausen BS, et al. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes [J]. Clin Biochem, 2016, 49(3):232-236.
|
| [55] |
Dubin RF, Judd S, Scherzer R, et al. Urinary tubular injury biomarkers are associated with ESRD and death in the REGARDS study [J]. Kidney Int Rep, 2018, 3(5):1183-1192.
|
| [56] |
Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA consensus conference [J]. Am J Kidney Dis, 2014, 64(4):510-533.
|
| [57] |
Klessens CQ, Woutman TD, Veraar KA, et al. An autopsy study suggests that diabetic nephropathy is underdiagnosed [J]. Kidney Int, 2016, 90(1):149-156.
|